Clinical Trials Logo

Sleep Deprivation clinical trials

View clinical trials related to Sleep Deprivation.

Filter by:

NCT ID: NCT05560620 Completed - Cognitive Change Clinical Trials

Sleep Deprivation Study

Start date: June 3, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the measures of brain function, both neurophysiological (event-related potentials (ERPs) and functional (cognitive assessments), in response to sleep deprivation.

NCT ID: NCT05492812 Completed - Sleep Deprivation Clinical Trials

Sedation and Nursing Management in EEG Recording in Children

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Electroencephalogram (EEG) has an important place in establishing the correct diagnosis, providing appropriate intervention, and predicting the prognosis in the long term in children. When the literature is examined, it is seen that different sedative drugs (benzodiazepines, barbiturates, phenothiazine, chloral hydrate, hydroxyzine, melatonin, etc.) and their combinations are used to provide sedation during EEG recordings, but there is no ideal sedative drug. Nurses working in the field of pediatric neurology in EEG recordings; It has important roles in preparing the child and parent for the procedure, applying sedation before the procedure, performing the EEG recording properly, monitoring vital signs during the procedure, monitoring the effects of the sedative substance after the procedure, and sending the patient home safely. Pediatric nurses fulfill these roles by adopting a multidisciplinary team approach. In this context, the aim of our research is; The aim of this study is to evaluate the effects of chloral hydrate, hydroxyzine and melatonin, which are used as sedative agents before EEG recording in children, on sleep success, time to fall asleep, side effects and EEG background.

NCT ID: NCT05370339 Completed - Type 1 Diabetes Clinical Trials

Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes

Start date: June 15, 2022
Phase:
Study type: Observational

The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires regarding sleep, fear of hypoglycemia, and anxiety and depression. A subset of participants will additionally complete a qualitative interview session to obtain a deeper understanding of sleep disruptors and barriers and facilitators to improving sleep health.

NCT ID: NCT05280561 Completed - Clinical trials for Insomnia Due to Anxiety and Fear

Stress-induced Sleep Deficits and a Complementary Therapy

Sleep-Aid
Start date: July 25, 2021
Phase: N/A
Study type: Interventional

The COVID-19 pandemic and social isolation order induced stress/anxiety as well as cellphone dependence. As a result, sleep disruption and mental distress became major health concerns. Gamma-aminobutyric acid type-A receptor (GABAAR) is one of the key players in modulating sleep. Dihydromyricetin (DHM), an herbal compound, plays a role in GABAAR modulation and mitigating anxiety. The investigators' partner in China obtained 288 participants who completed the online survey to gain insight into how stress/anxiety and time spent on cellphones affected sleep and mood. The participants were then enrolled in a randomized placebo-controlled double-blind study to assess the effects of DHM on sleep and improvement on stress/anxiety and cellphone using time.

NCT ID: NCT05222477 Completed - Sleep Deprivation Clinical Trials

Abdominal Muscle Exercises on Nocturia and Sleep Quality in Women With Type 2 Diabetes

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

Nocturia is the leading cause of sleep disruption with its subsequent negative impact on general health and QoL for a large proportion of the adult population. Nocturia is prevalent in men and women of all ages but may be particularly bothersome in younger adults, in whom the consequences of sleep disturbance may be more detrimental for daytime functioning and possibly for health and mortality.The underlying causes of nocturia obviously influence the efficacy of different treatment options. Because a major cause of nocturia is overproduction of urine at night, nocturia may not respond to treatments designed to reduce urgency and increase bladder capacity or increase urine flow, such as agents for the management of bladder outlet obstruction.

NCT ID: NCT05162105 Completed - Sleep Deprivation Clinical Trials

Quick Returns - Sleep, Cognitive Functions and Individual Differences

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The project will contribute with new knowledge concerning how short rest periods between two consecutive shifts (<11h, often defined as a Quick Return (QR)) affects sleep and cognitive performance. The study will further examine whether individual differences in personality traits and genotypes may explain individual differences in performance and sleep. Data will be collected with a randomized cross-over design, in an experimental laboratory setting.

NCT ID: NCT05093413 Completed - Sleep Deprivation Clinical Trials

Olfactory Decision-making and Deprived Sleep

ODDS
Start date: January 14, 2021
Phase: N/A
Study type: Interventional

This research study will use magnetic resonance imaging (MRI) and olfactory stimuli to better understand the connection between sleep deprivation, brain activity, and olfaction in humans.

NCT ID: NCT05066581 Completed - Sleep Deprivation Clinical Trials

Vitoria Sleep Smart City: Interactive Intervention for Sleep Improvement

SMARTCITY
Start date: June 21, 2021
Phase: N/A
Study type: Interventional

Currently, the investigators know that there is a high and increasing prevalence of sleep quality and quantity deficits in the general population with the social and health consequences that this entails. There are numerous activity wristbands linked to mobile apps that analyze sleep, but none can generate individualized recommendations for improvement interacting with the person. The main objective of the current project is to develop a virtual and interactive sleep assistant to increase the quantity and quality of sleep. Secondary objectives being the improvement of daytime sleepiness and the quality of life of the persons. Methodology: 202 participants in active employment who meet the criteria of "poor sleepers" (defined by a Pittsburg test score >5) are divided into 2 study groups. 1. Intervention group: Sleep data will be collected using validated questionnaires (SATED and the Sleep Hygiene Index) and objectively employing an activity bracelet, in which weekly, through a live chat, the medical staff of the sleep units will offer recommendations for the improvement of the deficits detected. 2. Control group: Same protocol as the intervention group, but the participants will not receive the recommendations via the interactive chat.

NCT ID: NCT04955431 Completed - Inflammation Clinical Trials

Circadian Rhythm Disruption Effects on Smoke Inhalation

Start date: January 24, 2022
Phase: N/A
Study type: Interventional

Particulate matter exposure during smoke inhalation provokes inflammatory immune responses in people exposed to burning biomass including fire fighters and civilians. Persistent occupational exposure to particulate matter represents a unique hazard for firefighters, underpinning a burgeoning research area. This trial will evaluate the effects of sleep deprivation and circadian rhythm disruption on the inflammatory response to woodsmoke associated particulate matter exposure. Participants will undergo 2 experimental trials in a randomized cross-over design. Participants will have either an 8-hour sleep opportunity or a 4-hour sleep opportunity prior to reporting to lab for a 45 minute simulated firefighting trial (wood smoke associated particulate matter filtered to 2.5 um at a concentration of 250 ug/m^3, while exercising at a moderate intensity). The effects of sleep restriction and simulated firefighting will be measured.

NCT ID: NCT04818450 Completed - Critically Ill Clinical Trials

Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient

GASWAC
Start date: April 19, 2021
Phase: N/A
Study type: Interventional

The investigators proposed that gabapentin will increase slow-wave sleep in adult critically ill patients. Increasing slow-wave sleep will improve the patients' outcomes (shortening ICU length of stay, improving ventilator free days, increasing delirium free days) in critically ill patients, a university hospital, Thailand.